Duke Lupus Registry for Systemic and Cutaneous Lupus

This is an observational study, called the Duke Lupus Registry, for people with systemic lupus erythematosus (SLE) or cutaneous lupus. Researchers will collect information and blood samples during your regular doctor visits at Duke. The goal is to understand how lupus changes over time to improve care and support future research on topics like heart health, pregnancy, and quality of life. This study does not involve new treatments; it focuses on observing your condition and current care.

Study design
This is an observational study with a planned enrollment of 1000 participants. It is a prospective cohort study, meaning participants are followed over time.
What's involved
You will complete a questionnaire and may provide a small blood sample during your regularly scheduled office visits. No extra visits to Duke are required.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT00512694

Duke Lupus Registry

Recruiting
Not specifiedAges 18+Observational
Duke University
~1,000 participants
Updated 2026-01-08 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring

A primary outcome measure isn't published for this study.

Systemic Lupus Erythematosus
Cutaneous Lupus
1 sites across 1 states
North Carolina1
  • Megan E. B. Clowse, MD, MPH · PRINCIPAL_INVESTIGATOR · Duke University

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Diagnosis of Systemic Lupus Erythematosus or Cutaneous Lupus
Patient of a rheumatologist at Duke University Medical Center

Exclusion

Inability to travel to Duke for follow-up visits
Inability to speak English
Not able to provide informed consent